FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

S Alvino

Research Profile

Disorders

Chemicals & Drugs

Genes & Molecular Sequences

Physiology

Procedures

Immunophenotyping

Concepts & Ideas

Biological Markers

Co-author Network

Publications

TOP 3
Claudia Greco; S Alvino; G Del Monte; Irene Venturo; M Lopez
Potential usefulness of serum p53 for laboratory management of plasma cell dyscrasias.
Claudia Greco; S Alvino; Simonetta Buglioni; Daniela Assisi; R Lapenta; A Grassi; Vittoria Stigliano; Marcella Mottolese; Vincenzo Casale
Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
S Alvino; M Marcucci; D Canzoniere; A Mosiello; G Del Monte; Irene Venturo; M Rinaldi; Giuseppe M Gandolfo; M Lopez; Claudia Greco
[IL-6, p53 and proto-oncogene c-myc play different roles as biological markers of plasma cell dyscrasias].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of S Alvino (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Claudia Greco; S Alvino; G Del Monte; Irene Venturo; M Lopez
Potential usefulness of serum p53 for laboratory management of plasma cell dyscrasias.
Journal of experimental & clinical cancer research : CR 2003;22(4):607-12.
2001: Claudia Greco; S Alvino; Simonetta Buglioni; Daniela Assisi; R Lapenta; A Grassi; Vittoria Stigliano; Marcella Mottolese; Vincenzo Casale
Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
Anticancer research 2001;21(5):3185-92.
1999: S Alvino; M Marcucci; D Canzoniere; A Mosiello; G Del Monte; Irene Venturo; M Rinaldi; Giuseppe M Gandolfo; M Lopez; Claudia Greco
[IL-6, p53 and proto-oncogene c-myc play different roles as biological markers of plasma cell dyscrasias].
La Clinica terapeutica 1999;150(3):197-202.
1997: Claudia Greco; S Alvino; M Marcucci; A Mosiello; Fabrizio Mattei; F Valente; V Francavilla; C Arista; Anna Maria Cianciulli; Giuseppe M Gandolfo
Possible use of lymphoid CD subsets as prognostic markers for plasma cell dyscrasias.
European journal of histochemistry : EJH 1997;41 Suppl 2():21-2.
1997: Claudia Greco; S Alvino; A Mosiello; G Avilii; Fabrizio Mattei; V Francavilla; F Valente; G Del Monte; Anna Maria Cianciulli; Giuseppe M Gandolfo
Monoclonal gammopathies with a high MC elicit altered phenotypic and genotypic features.
European journal of histochemistry : EJH 1997;41 Suppl 2():19-20.
1994: Claudia Greco; Giuseppe M Gandolfo; Fabrizio Mattei; Angela Gradilone; S Alvino; L I Pastore; Vincenzo Casale; P Casole; A Grassi; Anna Maria Cianciulli
Detection of C-myb genetic alterations and mutant p53 serum protein in patients with benign and malignant colon lesions.
Anticancer research 1994;14(3B):1433-40.
1994: Claudia Greco; Franco Ameglio; S Alvino; Anna Maria Cianciulli; M Giovannelli; Fabrizio Mattei; Gaetano Vitelli; Irene Venturo; Massimo Lopez; Giuseppe M Gandolfo
Selection of patients with monoclonal gammopathy of undetermined significance is mandatory for a reliable use of interleukin-6 and other nonspecific multiple myeloma serum markers.
Acta haematologica 1994;92(1):1-7.
1992: Claudia Greco; Gaetano Vitelli; Anna Maria Cianciulli; S Alvino; Giuseppe M Gandolfo; Franco Ameglio
Are serum interleukin-6 levels always useful for differentiating monoclonal gammopathies in unselected patients?
Blood 1992;79(8):2173-4.